EA200400279A1 - Сольваты гидрохлорида лерканидипина и новые кристаллические формы гидрохлорида лерканидипина, полученные из указанных сольватов - Google Patents
Сольваты гидрохлорида лерканидипина и новые кристаллические формы гидрохлорида лерканидипина, полученные из указанных сольватовInfo
- Publication number
- EA200400279A1 EA200400279A1 EA200400279A EA200400279A EA200400279A1 EA 200400279 A1 EA200400279 A1 EA 200400279A1 EA 200400279 A EA200400279 A EA 200400279A EA 200400279 A EA200400279 A EA 200400279A EA 200400279 A1 EA200400279 A1 EA 200400279A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- solvates
- lercanidipine hydrochloride
- crystalline forms
- specified
- new crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение раскрывает новые сольваты гидрохлорида лерканидипина с органическими растворителями, новые кристаллические формы (III) и (IV) гидрохлорида лерканидипина, полученные из указанных сольватов после удаления растворителя, и фармацевтические композиции, содержащие в качестве активного компонента по меньшей мере одну кристаллическую форму (III) и (IV) гидрохлорида лерканидипина.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI001727A ITMI20011727A1 (it) | 2001-08-06 | 2001-08-06 | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
PCT/EP2002/008700 WO2003014085A1 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200400279A1 true EA200400279A1 (ru) | 2004-06-24 |
Family
ID=11448246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400279A EA200400279A1 (ru) | 2001-08-06 | 2002-08-05 | Сольваты гидрохлорида лерканидипина и новые кристаллические формы гидрохлорида лерканидипина, полученные из указанных сольватов |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1423367B1 (ru) |
JP (1) | JP2005502648A (ru) |
KR (1) | KR100912664B1 (ru) |
CN (1) | CN100494175C (ru) |
AR (1) | AR037230A1 (ru) |
AT (1) | ATE294162T1 (ru) |
AU (1) | AU2002331390B2 (ru) |
BR (1) | BR0211738A (ru) |
DE (1) | DE60203919D1 (ru) |
EA (1) | EA200400279A1 (ru) |
ES (1) | ES2209684T1 (ru) |
HR (1) | HRP20040157A2 (ru) |
HU (1) | HUP0401161A3 (ru) |
IL (2) | IL153916A0 (ru) |
IT (1) | ITMI20011727A1 (ru) |
MX (1) | MXPA04001073A (ru) |
NO (1) | NO20040479L (ru) |
PE (1) | PE20030350A1 (ru) |
PL (1) | PL369449A1 (ru) |
UY (1) | UY27409A1 (ru) |
WO (1) | WO2003014085A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
BRPI0616169B8 (pt) | 2005-09-16 | 2021-05-25 | Glenmark Pharmaceuticals Ltd | cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina |
US20100104649A1 (en) * | 2007-03-05 | 2010-04-29 | Actavis Group Ptc Ehf | Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate |
WO2008136393A1 (ja) * | 2007-04-27 | 2008-11-13 | Ajinomoto Co., Inc. | ラクタム化合物の結晶形およびその製造方法 |
EP2585051B2 (en) | 2010-06-23 | 2020-04-08 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
EP2654729B1 (en) | 2010-12-24 | 2016-05-04 | KRKA, d.d., Novo mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
-
2001
- 2001-08-06 IT IT2001MI001727A patent/ITMI20011727A1/it unknown
-
2002
- 2002-08-02 AR ARP020102957A patent/AR037230A1/es not_active Application Discontinuation
- 2002-08-05 CN CNB028155114A patent/CN100494175C/zh not_active Expired - Fee Related
- 2002-08-05 AU AU2002331390A patent/AU2002331390B2/en not_active Ceased
- 2002-08-05 AT AT02767318T patent/ATE294162T1/de not_active IP Right Cessation
- 2002-08-05 KR KR1020047001791A patent/KR100912664B1/ko not_active IP Right Cessation
- 2002-08-05 JP JP2003519035A patent/JP2005502648A/ja active Pending
- 2002-08-05 MX MXPA04001073A patent/MXPA04001073A/es not_active Application Discontinuation
- 2002-08-05 HU HU0401161A patent/HUP0401161A3/hu unknown
- 2002-08-05 DE DE60203919T patent/DE60203919D1/de not_active Expired - Lifetime
- 2002-08-05 EP EP02767318A patent/EP1423367B1/en not_active Expired - Lifetime
- 2002-08-05 PL PL02369449A patent/PL369449A1/xx unknown
- 2002-08-05 WO PCT/EP2002/008700 patent/WO2003014085A1/en active IP Right Grant
- 2002-08-05 IL IL15391602A patent/IL153916A0/xx unknown
- 2002-08-05 EA EA200400279A patent/EA200400279A1/ru unknown
- 2002-08-05 ES ES02767318T patent/ES2209684T1/es active Pending
- 2002-08-05 BR BR0211738-0A patent/BR0211738A/pt not_active IP Right Cessation
- 2002-08-06 UY UY27409A patent/UY27409A1/es not_active Application Discontinuation
- 2002-08-06 PE PE2002000716A patent/PE20030350A1/es not_active Application Discontinuation
-
2003
- 2003-01-13 IL IL153916A patent/IL153916A/en unknown
-
2004
- 2004-02-03 NO NO20040479A patent/NO20040479L/no not_active Application Discontinuation
- 2004-02-18 HR HR20040157A patent/HRP20040157A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20030350A1 (es) | 2003-06-06 |
ITMI20011727A0 (it) | 2001-08-06 |
AR037230A1 (es) | 2004-11-03 |
EP1423367A1 (en) | 2004-06-02 |
WO2003014085A1 (en) | 2003-02-20 |
ATE294162T1 (de) | 2005-05-15 |
UY27409A1 (es) | 2003-03-31 |
CN1538958A (zh) | 2004-10-20 |
ES2209684T1 (es) | 2004-07-01 |
EP1423367B1 (en) | 2005-04-27 |
ITMI20011727A1 (it) | 2003-02-06 |
PL369449A1 (en) | 2005-04-18 |
AU2002331390B2 (en) | 2008-06-05 |
DE60203919D1 (de) | 2005-06-02 |
HUP0401161A3 (en) | 2009-04-28 |
IL153916A0 (en) | 2003-07-31 |
KR20040030932A (ko) | 2004-04-09 |
IL153916A (en) | 2008-07-08 |
HRP20040157A2 (en) | 2004-08-31 |
HUP0401161A2 (hu) | 2004-09-28 |
KR100912664B1 (ko) | 2009-08-17 |
NO20040479L (no) | 2004-02-03 |
JP2005502648A (ja) | 2005-01-27 |
BR0211738A (pt) | 2004-09-28 |
CN100494175C (zh) | 2009-06-03 |
MXPA04001073A (es) | 2005-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200300050A1 (ru) | Гликопептидфосфонатные производные | |
EA200400280A1 (ru) | Новые неочищенные и кристаллические формы гидрохлорида лерканидипина | |
EA200300788A1 (ru) | Производные замещенных алкиламинов и их применение | |
EA200400491A1 (ru) | Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции | |
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
NO20024614D0 (no) | N-heterosykliske derivater som NOS-hemmere | |
WO2002048157A3 (en) | Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
EA200300580A1 (ru) | Соединения лактама | |
NO20034660L (no) | Spiropyrazolforbindelser, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene for fremstilling av farmasoytiske preparater | |
EA200400467A1 (ru) | Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора | |
EA200401526A1 (ru) | Новые соединения и их применение | |
BRPI0412659A (pt) | isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto | |
ATE413388T1 (de) | Muskarin antagonisten | |
EA200300450A1 (ru) | Фармацевтические растворы соединений модафинила | |
DE60314441D1 (de) | Analyse pharmazeutischer löslichkeit und stabilität | |
EA200600694A1 (ru) | Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение | |
SE0200919D0 (sv) | Chemical compounds | |
EA200200732A1 (ru) | Замещенные производные фенилпиперазина, их получение и применение | |
EA200000431A2 (ru) | Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их | |
EA200400279A1 (ru) | Сольваты гидрохлорида лерканидипина и новые кристаллические формы гидрохлорида лерканидипина, полученные из указанных сольватов | |
EE05085B1 (et) | Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks | |
EA200300988A1 (ru) | Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина | |
EA200100984A1 (ru) | Новые кристаллические формы макролидного антибиотика | |
CY1110572T1 (el) | Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης |